These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30156322)

  • 1. Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.
    Liu Y; Wan B; Lin S
    Aliment Pharmacol Ther; 2018 Sep; 48(5):584-585. PubMed ID: 30156322
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey - author's reply.
    Wong RJ
    Aliment Pharmacol Ther; 2018 Sep; 48(5):585-586. PubMed ID: 30156318
    [No Abstract]   [Full Text] [Related]  

  • 3. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
    Kim D; Li AA; Ahmed A
    Liver Int; 2018 Oct; 38(10):1839-1848. PubMed ID: 29797393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.
    Wong RJ; Liu B; Bhuket T
    Aliment Pharmacol Ther; 2017 Nov; 46(10):974-980. PubMed ID: 28914448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States.
    Jiang ZG; Tsugawa Y; Tapper EB; Lai M; Afdhal N; Robson SC; Mukamal KJ
    Aliment Pharmacol Ther; 2015 Jul; 42(1):106-16. PubMed ID: 25913437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    Le MH; Devaki P; Ha NB; Jun DW; Te HS; Cheung RC; Nguyen MH
    PLoS One; 2017; 12(3):e0173499. PubMed ID: 28346543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.
    Caussy C; Soni M; Cui J; Bettencourt R; Schork N; Chen CH; Ikhwan MA; Bassirian S; Cepin S; Gonzalez MP; Mendler M; Kono Y; Vodkin I; Mekeel K; Haldorson J; Hemming A; Andrews B; Salotti J; Richards L; Brenner DA; Sirlin CB; Loomba R;
    J Clin Invest; 2017 Jun; 127(7):2697-2704. PubMed ID: 28628033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is associated with decreased lung function.
    Lee CH; Choi SH; Chung GE; Park B; Kwak MS
    Liver Int; 2018 Nov; 38(11):2091-2100. PubMed ID: 29660233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.
    Yu R; Shi Q; Liu L; Chen L
    BMC Gastroenterol; 2018 Apr; 18(1):51. PubMed ID: 29673321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.
    Yang BB; Chen YH; Zhang C; Shi CE; Hu KF; Zhou J; Xu DX; Chen X
    Endocrine; 2017 Feb; 55(2):582-590. PubMed ID: 27796814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma trans-fatty acid and risk of nonalcoholic fatty liver disease: New data from National Health and Nutrition Examination Survey (NHANES).
    Mantovani A
    Int J Cardiol; 2018 Dec; 272():329-330. PubMed ID: 30077528
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.
    Jiang ZG; Feldbrügge L; Tapper EB; Popov Y; Ghaziani T; Afdhal N; Robson SC; Mukamal KJ
    Aliment Pharmacol Ther; 2016 Mar; 43(6):734-43. PubMed ID: 26749582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.
    Moylan CA; Abdelmalek MF
    Hepatology; 2018 Oct; 68(4):1646-1648. PubMed ID: 29534302
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.